1. Home
  2. COHN vs PRPH Comparison

COHN vs PRPH Comparison

Compare COHN & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • PRPH
  • Stock Information
  • Founded
  • COHN 1999
  • PRPH 1989
  • Country
  • COHN United States
  • PRPH United States
  • Employees
  • COHN N/A
  • PRPH N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • PRPH Health Care
  • Exchange
  • COHN Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • COHN 21.6M
  • PRPH 21.9M
  • IPO Year
  • COHN N/A
  • PRPH 1997
  • Fundamental
  • Price
  • COHN $10.94
  • PRPH $0.51
  • Analyst Decision
  • COHN
  • PRPH
  • Analyst Count
  • COHN 0
  • PRPH 0
  • Target Price
  • COHN N/A
  • PRPH N/A
  • AVG Volume (30 Days)
  • COHN 3.1K
  • PRPH 1.4M
  • Earning Date
  • COHN 11-03-2025
  • PRPH 11-12-2025
  • Dividend Yield
  • COHN 9.43%
  • PRPH N/A
  • EPS Growth
  • COHN 37.63
  • PRPH N/A
  • EPS
  • COHN 1.14
  • PRPH N/A
  • Revenue
  • COHN $133,173,000.00
  • PRPH $5,588,000.00
  • Revenue This Year
  • COHN N/A
  • PRPH $221.82
  • Revenue Next Year
  • COHN N/A
  • PRPH N/A
  • P/E Ratio
  • COHN $9.31
  • PRPH N/A
  • Revenue Growth
  • COHN 78.63
  • PRPH N/A
  • 52 Week Low
  • COHN $6.10
  • PRPH $0.22
  • 52 Week High
  • COHN $13.25
  • PRPH $2.50
  • Technical
  • Relative Strength Index (RSI)
  • COHN 50.79
  • PRPH 56.32
  • Support Level
  • COHN $10.55
  • PRPH $0.45
  • Resistance Level
  • COHN $10.94
  • PRPH $0.54
  • Average True Range (ATR)
  • COHN 0.20
  • PRPH 0.06
  • MACD
  • COHN 0.03
  • PRPH -0.01
  • Stochastic Oscillator
  • COHN 67.90
  • PRPH 30.16

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: